Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Equilin: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 454159385 of page Equilin for the Chem/Drugbox validation project (updated: 'DrugBank', 'CAS_number'). |
CrafterNova (talk | contribs) →Pharmacology: removed self-redirect |
||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Equilin|oldid=454159385}} 454159385] of page [[Equilin]] with values updated to verified values.}} |
|||
{{Distinguish|Equilenin}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = verified |
|||
⚫ | |||
| Watchedfields = verified |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| image = Equilin.svg |
| image = Equilin.svg |
||
| width = 225px |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|||
⚫ | |||
| pregnancy_US = <!-- A / B / C / D / X --> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|||
| legal_CA = |
|||
| legal_UK = |
|||
| legal_US = |
|||
⚫ | |||
⚫ | |||
| class = [[Estrogen (medication)|Estrogen]] |
|||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
|||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|CAS}} |
|||
| CAS_number = <!-- blanked - oldvalue: 474-86-2 --> |
|||
| |
| CAS_number = 474-86-2 |
||
| CAS_supplemental = |
|||
⚫ | |||
| ATC_prefix = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| PubChem = 223368 |
| PubChem = 223368 |
||
| IUPHAR_ligand = |
|||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = DB02187 |
| DrugBank = DB02187 |
||
Line 35: | Line 50: | ||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
| ChEMBL = 323533 |
| ChEMBL = 323533 |
||
| synonyms = Δ<sup>7</sup>-Estrone; 7-Dehydroestrone; Estra-1,3,5(10),7-tetraen-3-ol-17-one |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=18 | H=20 | O=2 |
| C=18 | H=20 | O=2 |
||
⚫ | |||
| molecular_weight = 268.355 g/mol |
|||
⚫ | |||
| InChI = 1/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18+/m1/s1 |
|||
| InChIKey = WKRLQDKEXYKHJB-HFTRVMKXBJ |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18+/m1/s1 |
| StdInChI = 1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18+/m1/s1 |
||
Line 47: | Line 60: | ||
| StdInChIKey = WKRLQDKEXYKHJB-HFTRVMKXSA-N |
| StdInChIKey = WKRLQDKEXYKHJB-HFTRVMKXSA-N |
||
}} |
}} |
||
'''Equilin''' is a [[natural product|naturally occurring]] [[estrogen (medication)|estrogen]] [[sex hormone]] found in [[horse]]s as well as a [[medication]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA298|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|page=495}}</ref><ref name="pmid16112947">{{cite journal | vauthors = Kuhl H | title = Pharmacology of estrogens and progestogens: influence of different routes of administration | journal = Climacteric | volume = 8 | pages = 3–63 | year = 2005 | issue = Suppl 1 | pmid = 16112947 | doi = 10.1080/13697130500148875 | s2cid = 24616324 | url = http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf}}</ref><ref name="pmid24176763">{{cite journal | vauthors = Bhavnani BR, Stanczyk FZ | title = Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action | journal = J. Steroid Biochem. Mol. Biol. | volume = 142 | pages = 16–29 | date = July 2014 | pmid = 24176763 | doi = 10.1016/j.jsbmb.2013.10.011 | s2cid = 1360563 }}</ref> It is one of the estrogens present in the estrogen [[combination drug]] preparations known as [[conjugated estrogens]] (CEEs; e.g. '''Premarin''') and [[esterified estrogens]] (EEs; e.g. '''Estratab''', '''Menest''').<ref name="pmid16112947" /><ref name="pmid24176763" /> CEEs is the most commonly used form of estrogen medications in [[hormone replacement therapy]] (HRT) for [[menopausal symptoms]] in the [[United States]].<ref name="pmid24176763" /> [[Estrone sulfate (medication)|Estrone sulfate]] is the major estrogen in CEEs (about 50%) while equilin sulfate is the second major estrogen in the formulation, present as about 25% of the total.<ref name="pmid16112947" /><ref name="pmid24176763" /> |
|||
==Pharmacology== |
|||
===Pharmacodynamics=== |
|||
Equilin is an estrogen, or an [[agonist]] of the [[estrogen receptor]]s (ERs), the [[ERα]] and [[ERβ]].<ref name="pmid16112947" /> In terms of [[relative binding affinity]] for the ERs, equilin has about 13% and 49% of that of estradiol for the ERα and ERβ, respectively.<ref name="pmid16112947" /> Analogously to the reversible transformation of [[estrone (medication)|estrone]] into [[estradiol (medication)|estradiol]] by [[17β-hydroxysteroid dehydrogenase]], equilin can be converted into the more potent estrogen [[17β-dihydroequilin]] in the body.<ref name="pmid16112947" /><ref name="pmid24176763" /> This estrogen has about 113% and 108% of the relative binding affinities of estradiol for the ERα and ERβ, respectively.<ref name="pmid16112947" /><ref name="pmid24176763" /> Equilin is present in CEEs in the form of equilin sulfate, which itself is inactive and acts as a [[prodrug]] of equilin via [[steroid sulfatase]].<ref name="pmid16112947" /><ref name="pmid24176763" /> |
|||
Similarly to [[synthetic compound|synthetic]] estrogens like [[ethinylestradiol]], equilin and CEEs have disproportionate effects in certain [[tissue (biology)|tissue]]s such as the [[liver]] and [[uterus]] relative to [[bioidentical]] human estrogens like estradiol and estrone.<ref name="pmid16112947" /> Because of their disproportionate potency in the liver, equilin and CEEs have relatively increased effects on [[liver protein synthesis]] compared to estradiol.<ref name="pmid16112947" /> |
|||
A dosage of 0.25 mg/day equilin sulfate is equivalent to 0.625 mg/day CEEs in terms of relief from [[hot flash]]es.<ref name="pmid16112947" /> At a dosage of 0.625 mg/day equilin sulfate, the increases in circulating levels of [[sex hormone-binding globulin]] (SHBG), [[corticosteroid-binding globulin]], and [[angiotensinogen]] were 1.5 to 8 times those observed with [[estrone sulfate (medication)|estrone sulfate]].<ref name="pmid16112947" /> Equilin has about 42% of the relative potency of CEEs in the [[vagina]] and 80% of the relative potency of CEEs in the [[uterus]], while its more active form, 17β-dihydroequilin, has about 83% of the relative potency of CEEs in the vagina and 200% of the relative potency of CEEs in the uterus.<ref name="pmid16112947" /> |
|||
{{Relative oral potencies of estrogens}} |
|||
===Pharmacokinetics=== |
|||
Equilin has about 8% of the [[relative binding affinity]] of [[testosterone]] for SHBG, relative to 12% in the case of [[estrone (medication)|estrone]].<ref name="pmid16112947" /> In terms of [[plasma protein binding]], it is bound 26% to SHBG and 13% to [[human serum albumin|albumin]].<ref name="pmid16112947" /> The [[metabolic clearance rate]]s of equilin and equilin sulfate are 2,640 L/day/m<sup>2</sup> and 175 L/day/m<sup>2</sup>, respectively.<ref name="pmid16112947" /> In accordance, the [[biological half-life]] of equilin sulfate is substantially longer than that of equilin.<ref name="pmid16112947" /> Equilin is converted into [[17β-dihydroequilin]] in the [[liver]] and in other [[tissue (biology)|tissue]]s.<ref name="pmid16112947" /><ref name="pmid24176763" /> Equilin and 17β-dihydroequilin can also be transformed into [[equilenin]] and [[17β-dihydroequilenin]].<ref name="pmid16112947" /><ref name="pmid24176763" /> Equilin is [[excretion|excreted]] in the form of [[glucuronide]] conjugates.<ref name="pmid16112947" /> |
|||
==Chemistry== |
|||
{{See also|List of estrogens#Equine estrogens}} |
|||
Equilin, also known as δ<sup>7</sup>-estrone or as 7-dehydroestrone, as well as estra-1,3,5(10),7-tetraen-3-ol-17-one, is a [[natural product|naturally occurring]] [[estrane]] [[steroid]] and an [[structural analog|analogue]] of [[estrone (medication)|estrone]].<ref name="pmid16112947" /><ref name="pmid24176763" /> In terms of [[chemical structure]] and [[pharmacology]], equilin is to [[17β-dihydroequilin]] (δ<sup>7</sup>-17β-estradiol) as estrone is to [[estradiol (medication)|estradiol]].<ref name="pmid16112947" /><ref name="pmid24176763" /> |
|||
==References== |
|||
{{Reflist}} |
|||
{{Estrogens and antiestrogens}} |
|||
{{Estrogen receptor modulators}} |
|||
[[Category:Sterols]] |
|||
[[Category:Phenols]] |
|||
[[Category:Estranes]] |
|||
[[Category:Estrogens]] |
|||
[[Category:Human drug metabolites]] |
|||
[[Category:Ketones]] |
|||
[[Category:Prodrugs]] |